Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Search

Contact us

07 3737 4500

PO Box 3787

South Brisbane QLD 4101
Become a patient

Dr Luke Nicholls

BASc(Hons), MBBS, FRANZCR

  • Radiation Oncologist
Become a patient Refer a patient
Redland
07 3050 9000 07 3050 9001
admin.redland@icon.team

Biography

Dr Luke Nicholls is dedicated to providing high-quality, evidence-based care, guided by clear and compassionate communication. He values building trusting relationships with patients and their loved ones, supporting shared decision-making at every step.

Dr Luke Nicholls is a radiation oncologist at Icon Cancer Centre Redland. Raised in Redland City, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree at the University of Queensland in 2012, followed by specialist training in radiation oncology across Queensland. Dr Nicholls undertook a clinical fellowship at the internationally renowned Royal Marsden Hospital in London where he gained experience in prostate cancer management and clinical trials. He completed a second fellowship at Icon Cancer Centre Greenslopes, specialising in stereotactic radiation therapy. In 2020, he became a fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR).

With a strong commitment to research, education, and quality improvement, Dr Nicholls has published peer-reviewed work in areas including lung cancer, prostate cancer, medical education and stereotactic radiation therapy. He is a senior lecturer at the University of Queensland and an examiner for RANZCR. He also contributes as a reviewer for the Journal of Medical Imaging and Radiation Oncology (JMIRO) and Journal of Medical Radiation Sciences (JMRS).

Publications

  • E. Chapman, L. Nicholls, Y-E. Suh, D. Levine, D. ap Dafydd, N. Van As. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion. Radiother Oncol. 2023 March: 180:109461. Epub 2023 Jan 9.

  • L. Nicholls, E. Chapman, V. Khoo, Y-e. Suh, N. Tunariu, Y. Wang, N. van As. Metastasis directed therapy in prostate cancer: prognostic significance of the ESTRO/EORTC classification in oligometastatic bone disease. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):63-69. Epub 2021 Oct 29.

  • L. Nicholls, Y. Suh, A, Tree, D. Henderson, K. Morrison, E. Chapman, A. Sohaib, C. Jones, H. Taylor, N. van As. Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial. Clin Transl Radiat Oncol. 2020 Oct 20;25:88-93.

  • L. Nicholls, M. Pinkham, A. Bernard, R. Lusk, T. Watkins, S. Olsen, B. Hall, M. Foote. Radiological kinetics of brain metastases and clinical implications. Clin Oncol 2019 Jan;31(1):34-40.

  • L. Nicholls, B. Bravery, R. Chelvarajah, K. Shi, M. Tieu, S. Turner, A. Windsor. The status of radiation oncology teaching in Australian and New Zealand medical schools. J Med Imaging Radiat Oncol. 2018 Dec;62(6):828-834.